Differential effects of peroxisome proliferator activated receptor-γ (PPARγ) ligands in proximal tubular cells: Thiazolidinediones are partial PPARγ agonists

This publication has 43 references indexed in Scilit:

• PPAR Agonists Protect Mesangial Cells from Interleukin 1β-Induced Intracellular Lipid Accumulation by Activating the ABCA1 Cholesterol Efflux Pathway
  Journal of the American Society of Nephrology, 2003
• Troglitazone, a Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand, Selectively Induces the Early Growth Response-1 Gene Independently of PPARγ
  Journal of Biological Chemistry, 2003
• 15-Deoxy-Δ12,14-prostaglandin J2 regulates mesangial cell proliferation and death
  Kidney International, 2002
• Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats
  Kidney International, 2001
• A Cyclopentenone Prostaglandin Activates Mesangial MAP Kinase Independently of PPARγ
  Biochemical and Biophysical Research Communications, 2001
• Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion
  Kidney International, 2000
• 15-deoxy-Δ12,14PGJ2 induces diverse biological responses via PPARγ activation in cancer cells
  Prostaglandins & Other Lipid Mediators, 2000
• Albumin stimulates p44/p42 extracellular-signal-regulated mitogen-activated protein kinase in opossum kidney proximal tubular cells
  Clinical Science, 2000
• Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
  Science, 1996
• The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996